{"organizations": [], "uuid": "6a2f409ce73d643cf62a49be3e7d879baec4b7f1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-orexigen-therapeutics-enters-dip-c/brief-orexigen-therapeutics-enters-dip-credit-and-security-agreement-with-wilmington-trust-idUSFWN1QU0DM", "country": "US", "domain_rank": 408, "title": "BRIEF-Orexigen Therapeutics Enters Dip Credit And Security Agreement With Wilmington Trust​", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-12T12:29:00.000+02:00", "replies_count": 0, "uuid": "6a2f409ce73d643cf62a49be3e7d879baec4b7f1"}, "author": "", "url": "https://www.reuters.com/article/brief-orexigen-therapeutics-enters-dip-c/brief-orexigen-therapeutics-enters-dip-credit-and-security-agreement-with-wilmington-trust-idUSFWN1QU0DM", "ord_in_thread": 0, "title": "BRIEF-Orexigen Therapeutics Enters Dip Credit And Security Agreement With Wilmington Trust​", "locations": [], "entities": {"persons": [{"name": "wilm", "sentiment": "negative"}], "locations": [{"name": "wilmington", "sentiment": "none"}], "organizations": [{"name": "wilmington trust", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "orexigen therapeutics inc", "sentiment": "none"}, {"name": "ington trust​ reuters staff", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 30 AM / in 5 minutes BRIEF-Orexigen Therapeutics Enters Dip Credit And Security Agreement With Wilmington Trust​ Reuters Staff 1 Min Read March 12 (Reuters) - Orexigen Therapeutics Inc: * OREXIGEN THERAPEUTICS - ‍ ENTERED DIP CREDIT AND SECURITY AGREEMENT WITH WILMINGTON TRUST, AMONG OTHERS, SUBJECT TO APPROVAL OF BANKRUPTCY COURT​ * OREXIGEN THERAPEUTICS SAYS DIP LOAN AGREEMENT PROVIDES FOR A $70.4 MILLION DEBTOR-IN-POSSESSION CREDIT FACILITY - SEC FILING Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-03-12T12:29:00.000+02:00", "crawled": "2018-03-12T12:40:32.008+02:00", "highlightTitle": ""}